Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: J Am Coll Surg. 2012 Feb 28;214(4):640–647. doi: 10.1016/j.jamcollsurg.2011.12.036

Table 3.

Morbidity Before (Group 1) and After (Group 2) Permissive Hypercapnia

Morbidity Group 1 (n = 42) Group 2 (n = 49) p Value
Morbidity (overall), % 83.3 65.3 0.052
Neurologic, % 45.2 26.5 0.06
Cardiac, % 2.4 2.0 1.0
Repeat tube thoracostomy, % 35.7 10.2 0.003*
O2 requirement at discharge, % 21.4 22.4 0.94
Persistent pulmonary disease, % 14.3 10.2 0.56
Recurrent CDH, % 4.76 6.1 1.0
Gastrointestinal (all), % 19.1 20.4 0.87
Nissen, % 9.5 4.1 0.41
Gastrostomy, % 16.7 12.2 0.54
Nissen + Gastrostomy, % 9.5 4.1 0.41
Hematologic, % 19.1 6.1 0.10
Infection, % 14.3 20.4 0.44
Renal, % 7.1 0 0.09
ECMO, % 61.9 28.6 0.001*
Days on ECMO, mean ± SEM 15.2 ± 1.6 13.2 ± 2.7 0.49
iNO, n (%) 12/37 (32.4) 27/46 (58.7) 0.02*
HFOV, n (%) 26/37 (70.2) 34/45 (75.6) 0.59
Timing of repair, d, mean ± SEM 5.9 ± 1.01 9 ± 0.93 0.03*
Days intubated after repair, mean ± SEM 25 ± 3.9 19.9 ± 9.1 0.61
Days intubated after repair (modified), mean ± SEM 26 ± 3.9 11 ± 1.5 0.002*
Hospital stay, d, mean ± SEM 50.9 ± 7.9 42.2 ± 9.2 0.48
*

Denotes statistical significance, p < 0.05.

Variation in group size secondary to unobtainable chart data.

CDH, congenital diaphragmatic hernia; ECMO, extracorporeal membrane oxygenation; HFOV, high frequency oscillatory ventilation; iNO, inhaled nitric oxide.